Hydroxychloroquine Sulfate Tablets — Class III drug recall D-66373-001
Terminated recall by Sandoz Incorporated, reported 2013-10-16, distributed nationwide. Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP,
| Recall number | D-66373-001 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sandoz Incorporated, Broomfield, CO, United States |
| Recall initiated | 2013-09-25 |
| Classified | 2013-10-10 |
| Reported by FDA | 2013-10-16 |
| Terminated | 2014-07-16 |
| Distributed | Nationwide (US) |
| Quantity | 25,830 bottles |
| NDC | 00781-1407-01 |
| Lot numbers | BU3417 |
| Expiration dates | 2014-06 |
Product
Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.
Reason for recall
Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-66373-001. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.